Moderna, Inc. (MRNA)

It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.

Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.

Trading volumes dropping on major indexes, U.K. teams begin human trials on a Covid-19 vaccine, and the U.S. Senate wants another stimulus package addition.

A look at some names that Robinhood brokerage CEO Tenev tells us young people are buying.

Will tech continue to trend toward leadership? Who among us can remember when it has not?

Welcome to the new era. Social distancing is not without risks, but it is as good as it gets.

Let's take a look at the charts and indicators.

The rise in equity futures pricing was born of optimism from the president's task force draft guideline on reopening parts of the U.S. economy and Gilead Sciences' somewhat positive results on its remdisivir anti-viral treatment.

How has my book evolved since the Fed and Treasury rode into town? Here's how.

I do think the key to reopening this economy is one of greatly expanded testing for Covid-19, once a reliable treatment has made it past clinical testing, and into mass production.

Consider these stock model ideas: virus groups, work remotely, and fiscal.

St. Louis Fed Pres. James Bullard sees unemployment possibly hitting 30%, while GDP could ultimately contract 50%.

If this group begins to outperform, then I'd use it as an indication of caution.

Here again is my approach and my three stock groups: 'rebound', 'revenue' and 'virus'.

I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.

When the central bank is on top of their game as they have been of late, credit must go where credit is due.

The race is on. The prize could be countless lives saved and perhaps billions of dollars in revenue.

Amid a flood of corporate warnings over the coronavirus, all the major stock market indexes finished last month down 6.4% to 10.1%.

I'll stick to the three-pronged approach... the Rebound group, the Virus group, and the Revenue group.

This is the time to high grade your portfolio, take some losses and move to better stocks.

These companies should continue to work, while we wait for a cure or a vaccine or the darned virus to run its course.

Check out just a few of the year-to-date moves coming into Thursday on 8 companies you've never heard of before the last week or two.

Hot money will be attracted to stocks that show promise in dealing with the coronavirus.

Only one of these scenarios is going to get you in and out of this market with your assets intact and your portfolio stronger.

Is this the end of the world? No. You still need to plan for your financial well-being, even as the CDC tells us 'this might be bad.'

This entirely logical scenario would pull the rug out from under the bull market.

Massachusetts biotech works on drug development based on messenger RNA.

These companies all could be strong -- even if the 2019 nCoV fear spreads.